Good MorningThe equities market ended a down week on a sour note with the major indices flat to slightly down on Friday. Traders are wary of new developments in the earnings outlook that suggests 2020’s robust rebound will slow in 2021.
The detail investors need to stay focused on is that revenue and earnings growth will continue for the S&P 500 in 2021 whether or not growth accelerates. Looking at the market from that perspective, price weakness in the major indices will most likely lead to gains in the 2nd half of the year.
This week the market will be focused on economic data. There are a dozen major reports due out over the week including the Leading Indicators, Consumer Spending, Personal Income, and Pending Home Sales and any could be the trigger for a market sell-off. If one comes, be ready with some cash to scoop up the deals.
Featured: Man Who Predicted March 2020 Crash Makes Bold Tech Stock Prediction (Legacy Research) 
|
Markets | | | VistaGen Therapeutics (NASDAQ:VTGN) operates in the penny stock sector which can be the wild, wild west of the stock market. For every diamond in the rough, there are just as many failing companies or companies that will never be more than just penny stocks. Read the Full Story |
|
|
Stocks | | | Combine that with the fact that President Joe Biden has big infrastructure plans and it’s safe to say that industrial stocks are worth a look at this time. Here are 3 industrial stocks to buy that are showing relative strength. Read the Full Story |
|
Politics | | | Chinese Foreign Minister Wang Yi is calling on the U.S. to lift restrictions on trade and people-to-people contacts while ceasing what Beijing considers unwarranted interference in areas such as Taiwan, Hong Kong, Xinjiang and Tibet Read the Full Story |
|
|
Markets | | |
Shares of Palantir (NYSE:PLTR) stock got a big lift on February 19, 2021. First, the company got upgraded by Goldman Sachs (NYSE:GS) analyst Christopher Merwin. The analyst raised PLTR stock from neutral to buy with an accompanying price target of $34 (previously $13). Bullish investors also cheer... Read the Full Story |
|
Markets | | |
It’s setting up to be another strong quarter for The Home Depot (NYSE:HD). The home improvement retailer is expecting to report earnings per share of $2.61 on revenue of $30.45 billion. And the whisper number suggests that the company’s EPS may be even higher ($2.74).
Sequentially, th... Read the Full Story |
|
From Our PartnersAs demand comes back swinging, oil will be well worth watching this year. With a focus on what could be the biggest shale play in the U.S., this company may be about to capture Wall Street's attention | | | | Continue Reading |
|
Politics | | | Global shares were mostly lower on Monday, with Japan's benchmark rising but most others slipping despite hopes for a recovery from the coronavirus pandemic with the global rollout of vaccines.
France's CAC 40 slipped 1.1% in early trading to 5,708.39, while Germany's DAX dove 1.3% t... Read the Full Story |
|
Politics | | | The European Union on Monday imposed sanctions on 19 more officials in Venezuela accused of undermining democracy or rights abuses in the crisis-torn South American country.
EU foreign ministers targeted the 19 with asset freezes and travel bans “in view of the deteriorating situation... Read the Full Story |
|
Politics | | | LONDON — Researchers in Scotland say its COVID-19 vaccination program has led to a sharp drop in hospitalizations.
Scientists from the University of Edinburgh, the University of Strathclyde and Public Health Scotland found that the Pfizer vaccine reduced hospital admissions by as much... Read the Full Story |
|
Markets | | | Optimism rose among German businesses in February, according to a closely watched survey - despite a worrisome flattening out in the decline of infections.
The index of business sentiment compiled by the Ifo institute showed that industry continues to hold up better than public-facing... Read the Full Story |
|
Markets | | | Shares of Cooper Tire (NYSE:CTB) are up a robust 18% in early premarket trading and not because of the Q4 results. The company turned in a weaker than expected quarter and failed to give any guidance. The news that has shares rocketing higher is the announced takeover by Goodyear Tire & Rubber Company (NASDAQ:GT), Read the Full Story |
|
The Early Bird Stock Of The Day Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany. | | View Today's Stock Pick |
|
